Market Overview:
The global travelers vaccines market is expected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing number of international travelers, rising awareness about traveler’s health, and technological advancements in the field of vaccine development. Based on type, the global travelers vaccines market is segmented into meningococcal vaccine, Japanese encephalitis vaccine, yellow fever vaccine, hepatitis B vaccine, cholera vaccine and other vaccines. The meningococcal vaccination segment is expected to account for the largest share of the global travelers vaccines market in 2018 owing to its high prevalence rate and potential benefits associated with it such as prevention against meningitis and sepsis. Based on application, tourists are expected to account for the largest share of the global travelers vaccines market in 2018 followed by students and workers.
Product Definition:
A travelers vaccine is a vaccine that is designed to protect people who are traveling to areas where there is a risk of getting sick from certain diseases. These vaccines can help protect people against diseases such as yellow fever, typhoid fever, and hepatitis A.
Meningococcal Vaccine:
Meningococcal vaccines are primarily used to prevent bacterial meningitis and septicaemia. Bacterial meningitis is a serious infectious disease that causes inflammation of the brain, spinal cord, and membranes covering the nerves. It can lead to severe complications such as hearing loss, blindness, mental retardation or death. Septicaemia is an infection of the blood system caused by bacteria from one's own body (e.g., gastrointestinal tract) or from another source (e.
Japanese Encephalitis Vaccine:
The Japanese encephalitis vaccine is a vaccine that helps in preventing the disease of Japanese Encephalitis. The vaccination is usually given to people who are planning to travel to Japan, but it can also be given to travelers who have not been exposed yet and might come in contact with the virus while there. It protects against infection by antibodies produced by the body in response to an attack of the virus.
Application Insights:
The workers application segment accounted for the largest share of over 50.0% in 2017. The growing trend of working abroad on a permanent or temporary basis is anticipated to boost the demand for travelers vaccines among other applications during the forecast period. For instance, according to a study published by InterNations in 2018, it was found that around 1 million people from developed countries work abroad every year while 7 million people from developing countries do so.
The students application segment is expected to register the fastest growth at 5.4% over the forecast period owing to increasing travel activities and higher risk exposure due to lesser number of immunization against common diseases like measles, chickenpox, typhoid & cholera.
Regional Analysis:
North America dominated the global market in 2017. The growing number of international travelers and rising incidence of infectious diseases are some factors contributing to the growth of this regional market. In addition, increasing government initiatives for immunization drives and awareness campaigns about vaccines is expected to boost demand for these products over the forecast period.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to an increase in foreign tourist visits along with rise in medical tourism due to availability of effective treatment at affordable costs in this region. Moreover, a large population base with high-unmet clinical needs will further propel product demand during the estimated time span. Japan accounted for a major share within Asia Pacific due its high vaccination coverage coupled with low disease prevalence rate within country borders as well as low level of general awareness regarding meningococcal disease among people living within country borders (Honda et al., 2016).
Growth Factors:
- Increasing demand for travel vaccines due to globalisation and increasing number of international travellers.
- Growing awareness about the benefits of vaccination and their role in preventing diseases.
- Development of new and more effective vaccines against major diseases such as malaria, tuberculosis, etc.
- Expansion of public-private partnerships for vaccine development and distribution programmes across the globe
Scope Of The Report
Report Attributes
Report Details
Report Title
Travelers Vaccines Market Research Report
By Type
Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other
By Application
Tourists, Students, Workers, Others
By Companies
GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Travelers Vaccines Market Report Segments:
The global Travelers Vaccines market is segmented on the basis of:
Types
Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tourists, Students, Workers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Sanofi Pasteur
- Merck
- Pfizer
- CNBG
- Sanofi Pasteur MSD
- Serum Institute of India
- Biokangtai
Highlights of The Travelers Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Meningococcal Vaccine
- Japanese Encephalitis Vaccine
- Yellow Fever Vaccine
- Hepatitis Vaccine
- Cholera Vaccine
- Other
- By Application:
- Tourists
- Students
- Workers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Travelers Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Travelers vaccines are a type of vaccine that is designed to protect people who are traveling to areas where there is a risk of infection with certain diseases. These vaccines can help prevent the spread of these diseases when someone travels to an area where they may be exposed to them.
Some of the major players in the travelers vaccines market are GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai.
The travelers vaccines market is expected to register a CAGR of 7.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Travelers Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Travelers Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Travelers Vaccines Market - Supply Chain
4.5. Global Travelers Vaccines Market Forecast
4.5.1. Travelers Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Travelers Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Travelers Vaccines Market Absolute $ Opportunity
5. Global Travelers Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Travelers Vaccines Market Size and Volume Forecast by Type
5.3.1. Meningococcal Vaccine
5.3.2. Japanese Encephalitis Vaccine
5.3.3. Yellow Fever Vaccine
5.3.4. Hepatitis Vaccine
5.3.5. Cholera Vaccine
5.3.6. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Travelers Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Travelers Vaccines Market Size and Volume Forecast by Application
6.3.1. Tourists
6.3.2. Students
6.3.3. Workers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Travelers Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Travelers Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Travelers Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Travelers Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Travelers Vaccines Demand Share Forecast, 2019-2026
9. North America Travelers Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Travelers Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Travelers Vaccines Market Size and Volume Forecast by Application
9.4.1. Tourists
9.4.2. Students
9.4.3. Workers
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Travelers Vaccines Market Size and Volume Forecast by Type
9.7.1. Meningococcal Vaccine
9.7.2. Japanese Encephalitis Vaccine
9.7.3. Yellow Fever Vaccine
9.7.4. Hepatitis Vaccine
9.7.5. Cholera Vaccine
9.7.6. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Travelers Vaccines Demand Share Forecast, 2019-2026
10. Latin America Travelers Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Travelers Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Travelers Vaccines Market Size and Volume Forecast by Application
10.4.1. Tourists
10.4.2. Students
10.4.3. Workers
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Travelers Vaccines Market Size and Volume Forecast by Type
10.7.1. Meningococcal Vaccine
10.7.2. Japanese Encephalitis Vaccine
10.7.3. Yellow Fever Vaccine
10.7.4. Hepatitis Vaccine
10.7.5. Cholera Vaccine
10.7.6. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Travelers Vaccines Demand Share Forecast, 2019-2026
11. Europe Travelers Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Travelers Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Travelers Vaccines Market Size and Volume Forecast by Application
11.4.1. Tourists
11.4.2. Students
11.4.3. Workers
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Travelers Vaccines Market Size and Volume Forecast by Type
11.7.1. Meningococcal Vaccine
11.7.2. Japanese Encephalitis Vaccine
11.7.3. Yellow Fever Vaccine
11.7.4. Hepatitis Vaccine
11.7.5. Cholera Vaccine
11.7.6. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Travelers Vaccines Demand Share, 2019-2026
12. Asia Pacific Travelers Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Travelers Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Travelers Vaccines Market Size and Volume Forecast by Application
12.4.1. Tourists
12.4.2. Students
12.4.3. Workers
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Travelers Vaccines Market Size and Volume Forecast by Type
12.7.1. Meningococcal Vaccine
12.7.2. Japanese Encephalitis Vaccine
12.7.3. Yellow Fever Vaccine
12.7.4. Hepatitis Vaccine
12.7.5. Cholera Vaccine
12.7.6. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Travelers Vaccines Demand Share, 2019-2026
13. Middle East & Africa Travelers Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Travelers Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Travelers Vaccines Market Size and Volume Forecast by Application
13.4.1. Tourists
13.4.2. Students
13.4.3. Workers
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Travelers Vaccines Market Size and Volume Forecast by Type
13.7.1. Meningococcal Vaccine
13.7.2. Japanese Encephalitis Vaccine
13.7.3. Yellow Fever Vaccine
13.7.4. Hepatitis Vaccine
13.7.5. Cholera Vaccine
13.7.6. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Travelers Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Travelers Vaccines Market: Market Share Analysis
14.2. Travelers Vaccines Distributors and Customers
14.3. Travelers Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GlaxoSmithKline
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi Pasteur
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. CNBG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sanofi Pasteur MSD
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Serum Institute of India
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biokangtai
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
